wawa fertility

Idea

Introduction

Despite the fact that 1 out of 6 couples experience infertility, a number that is only going to grow in the future, we are still not good enough at treating patients.

At wawa fertility we believe we need a fundamentally different approach to fertility treatments. Despite the growing number of people that struggle to conceive, the current methods of fertility treatment are far from optimal. Costs are high, diagnostics take a long time and many patients in treatment experience mental health difficulties. The root cause of these challenges are lacking, biased and unstructured data within reproductive health.

We are a female founded company, powered by women, working for better treatment solutions for women. Together with our community of thousands of women in treatment we aim to fix the broken fertility treatment model.

We are doing this by enabling women to take control over their fertility journey via our patient focused app and community. At the same time the wawa platform allows clinics to monitor their patients during treatment, which enables them to change the course of treatment and use more clinical and health-related factors when evaluating the treatment and the chances of success.

In 2022 we closed 2.7m EUR in seed funding from MMC Ventures and Founders as well as a number of angel investors. Now we want to give our users and the women in our community the opportunity to also get fully onboard the wawa mission.

Substantial accomplishments to date

We launched the app in Denmark, Sweden and Norway in January 2022 and in September we also launched an Android version. Later last year we also launched our in-app social community before releasing the app in the UK in January 2023. The app has been downloaded more than 6,500 times and we know it works.

We have been consistently adding funding and capabilities to the wawa team to deliver on the mission. In May 2022 we closed 2.6m EUR in seed funding from MMC Ventures and Founders. This was complemented by an angel extension of 73.000 EUR. Throughout this period we have secured key hires across management positions and have a strong team in place to develop and market both the patient facing app and the clinic tool. This has been recognized several times in various media channels. For example Sifted declared us one if the Danish startups to watch in October 2022.

The research and pharmaceutical community have already expressed interest in our capabilities to collect and structure relevant data. In 2021 we entered a partnership with Merck to share knowledge and collaborate on better outcomes for patients and in December 2022 we landed our first trial recruitment project with biggest hospital in Denmark.

These achievements underline our progress to deliver on our mission to fix the broken fertility model. In short we are empowering women in treatment to create the necessary real-world-data base for optimising the fertility treatments of the future.

Monetisation strategy

Our overall go-to-market approach is a B2C2B-model. By achieving critical mass on the B2C user base we will have two major sources of revenue when fully developed:

1. We are solving a large clinic pain by matching them up with relevant patients. They will get access to more patients through onboarding and referrals from the wawa app as well as the tools to deliver better experiences to their patients. We will sell our clinic platform on an annual subscription model and a fee per patient we are referring to the clinic.

2. We are also aiming to launch “Evidence-as-a-Service” for research institutions and pharmaceutical companies, where we provide them with access to proprietary data and the opportunity to recruit patients for clinical trials from our user base.

Use of proceeds

The proceeds of this round will be pooled with the rest of our seed round including funds from VC funds and angel investors. We have two main priorities that will require investment over the coming two years:

- Expand the patient app and community to more countries and a larger audience.

- Launch and sell first version of clinic tool and start optimising fertility treatment from the clinic side.

The primary spend area for these priorities is salary for the talented people who develop, design, and market the above products.